-
Receipt of Anticoagulant Rx in ED Linked to Use at Six Months
drugs
December 26, 2019
For patients aged 65 years or older with atrial fibrillation, receipt of a prescription for an oral anticoagulant in the emergency department is associated with increased use of oral anticoagulants at six months ...
-
Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess For The Treatment Of Recent Onset Atrial Fibrillation
drugs
December 11, 2019
Correvio Pharma Corp., a specialty pharmaceutical company focused on commercializing hospital drugs, announced that the U.S. Food and Drug Administration (FDA) Cardiovascular ...
-
Apple Watch identified atrial fibrillation in small group of users
firstwordpharma
March 18, 2019
Study data presented at the American College of Cardiology (ACC) annual meeting indicate that the Apple Watch was able to spot atrial fibrillation (AF) in certain wearers.
-
J&J partners with Apple for ECG monitoring project
pharmaphorum
January 22, 2019
Apple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG) through its paces, signing an alliance with Johnson & Johnson.
-
Botox May Help Prevent Post-Op A-Fib
drugs
December 06, 2018
Botox has other uses beyond enhancing lips and minimizing facial wrinkles. Scientists now say it may help prevent atrial fibrillation after heart surgery......
-
Omeicos raises €17M to run phase 2 atrial fibrillation trial
fiercebiotech
November 05, 2018
Omeicos Therapeutics has raised €17 million ($19 million) to develop an atrial fibrillation candidate. The Forbion-led series C round sets...
-
Oral anticoagulants and antiplatelets linked to poor outcome in atrial fibrillation
europeanpharmaceuticalreview
August 31, 2018
The results challenged the use of combined oral anticoagulant and antiplatelet therapy in patients with atrial fibrillation, especially those without an indication for antiplatelet therapy.
-
Treatment rapidly reverses the effect of blood thinner dabigatran
worldpharmanews
July 13, 2017
At least 28 million prescriptions for blood thinners are filled by pharmacists yearly for the irregular heartbeat of atrial fibrillation, deep vein thrombosis, and other indications, according to the Department of Health and Human Services.